Delivery Order SPE2DB22D3009-SPE2DB24FAV15

Award Date 4/24/24
Potential Completion Date 4/25/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award SPE2DB22D1017|SPE2DB25FG0JZ was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,949,076 units of Terbinafine HCL 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,982.21 and an ultimate completion date of April 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Terbinafine HCL 250 MG Tablet 30S. The contract is a Firm Fixed Price, non-set-aside award with a ceiling value of $1,618.04 and a period of performance ending on May 29, 2025. Amerisourcebergen Drug Corp is also an awardee on a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 MG Tablet 30S, a prescription medication. The contract has a ceiling value of $2,161.05 and a completion date of June 16, 2025. The contract type is Firm Fixed Price. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,837.26 firm fixed-price delivery order is for the supply of 4,568,078,153 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. This award is not designated as a set-aside contract....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, with a ceiling value of $92,164.85, is for the delivery of terbinafine hydrochloride 250 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,584.30 and a completion date of June 23, 2025. The contract is for the delivery of 4568604491 - Terbinafine HCL 250 MG Tablet 30S, a pharmaceutical product. AmerisourceBergen Drug Corporation holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,163.16, is a Delivery Order for 4,566,761,020 units of Terbinafine HCL 250 mg tablets with a completion date of December 19, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of Terbinafine HCL 250 MG Tablet 30S, a medication, with a firm fixed price ceiling value of $1,920.72 and a completion date of May 20, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4,568,056,484 units of Terbinafine HCL 250 mg tablets. The contract has a ceiling value of $21,820.64 and a period of performance through April 29, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 mg tablets in 30-count packages. The contract has a ceiling value of $32,679.41 and a completion date of May 15, 2025. It is a firm-fixed-price contract, indicating that the agreed-upon price will not change. The contract is not set aside for any specific...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FAV15
    Delivery Order

This federal contract award, with identification number SPE2DB22D3009|SPE2DB24FAV15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564390398 - Terbinafine HCL 250 MG Tablet 30s, a pharmaceutical product. The contract has a ceiling value of $4,004.39 and a completion date of April 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) since 2002. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:06 PM